Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | APAF1 | O14727 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.42 |
| ▸ | FDPS | P14324 | 10/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL29390371 | 1.00 | MEN1 (0.58) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL3615950 | 0.96 | MEN1 (0.65) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL318471 | 0.95 | MEN1 (0.52) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL318175 | 0.94 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL318767 | 0.94 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL514445 | 0.94 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL318764 | 0.94 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL318566 | 0.94 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1331129 | 0.94 | MEN1 (0.68) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1293510 | 0.93 | MEN1 (0.62) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1802 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099153-A1 | DEVICE CAPABLE OF BONDING AND DEBONDING ON DEMAND | TESA SE (DE) | 2026-05-15 | — | — | WO | claimed |
| EP-4721970-A1 | BONDED STRUCTURE COMPRISING AN ELECTROCHEMICALLY DEBONDABLE ADHESIVE LAYER | Henkel AG & Co. KGaA (DE) | 2026-04-08 | — | — | EP | claimed |
| US-20260088410-A1 | ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS | HENKEL AG & CO KGAA (DE) | 2026-03-26 | — | — | US | claimed |
| US-12540262-B2 | Two component (2K) curable adhesive composition | HENKEL AG & CO. KGAA (DE) | 2026-02-03 | — | — | US | claimed |
| US-20250382408-A1 | EPOXY-TERMINATED ISOCYANATE PREPOLYMERS, AND PROCESS FOR THE PREPARATION THEREOF | BASF SE (DE) | 2025-12-18 | — | — | US | claimed |
| WO-2025242379-A1 | BONDED STRUCTURE COMPRISING AN ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM | HENKEL AG & CO. KGAA (DE) | 2025-11-27 | — | — | WO | claimed |
| US-12476286-B2 | Rechargeable calcium battery | SYRACUSE UNIVERSITY (US) | 2025-11-18 | — | — | US | claimed |
| WO-2025228672-A1 | TWO-COMPONENT (2K) CURABLE ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2025-11-06 | — | — | WO | claimed |
| WO-2025228674-A1 | ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM | HENKEL AG & CO. KGAA (DE) | 2025-11-06 | — | — | WO | claimed |
| EP-4644502-A1 | ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM | Henkel AG & Co. KGaA (DE) | 2025-11-05 | — | — | EP | claimed |
| US-6410799-B1 | LIQUID PHASE HEATING | INSTITUT FRANCAIS DU PETROLE (FR) | 2002-06-25 | — | — | US | claimed |
| US-20020035297-A1 | Hydroformylation process employing a catalyst based on cobalt and/or rhodium in a non-aqueous ionic solvent | INSTITUT FRANCAIS DU PETROLE (FR) | 2002-03-21 | — | — | US | claimed |
| US-20010039363-A1 | Process for hydroformylation using a catalyst based on cobalt and/or rhodium employed in a two-phase medium | INSTITUT FRANCAIS DU PETROLE (FR) | 2001-11-08 | — | — | US | claimed |
| EP-0748785-B1 | Process for moving the double bound in olefins using a catalytic composition comprising transition metal complexes | INST FRANCAIS DU PETROLE (FR) | 2000-05-31 | — | — | EP | claimed |
| US-6040263-A | Catalytic composition based on transition metal complexes, and a process for the hydrogenation of unsaturated compounds | INSTITUT FRANCAIS DU PETROLE (FR) | 2000-03-21 | — | — | US | claimed |
| EP-0776880-B1 | Process for the hydroformylation of olefinic compounds | INST FRANCAIS DU PETROLE (FR) | 2000-02-16 | — | — | EP | claimed |
| EP-0748653-B1 | New catalytic composition containing transition metals complexes and insatured compounds hydrogenation process | INST FRANCAIS DU PETROLE (FR) | 2000-01-26 | — | — | EP | claimed |
| US-5874638-A | Process for hydroformylation of olefinic compounds | INSTITUT FRANCAIS DU PETROLE (FR) | 1999-02-23 | — | — | US | claimed |
| US-5852130-A | Catalytic composition based on transition metal complexes, and a process for the hydrogenation of unsaturated compounds | INSTITUT FRANCAIS DU PETROLE (FR) | 1998-12-22 | — | — | US | claimed |
| US-5780702-A | Process for displacing the double bond in olefins using a catalytic composition based on transition metal complexes | INSTITUT FRANCAIS DU PETROLE (FR) | 1998-07-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035297-A1 | Hydroformylation process employing a catalyst based on cobalt and/or rhodium in a non-aqueous ionic solvent | NUDT1, IDH1, HRH4 | MEN1 3468/4885HSP90AA1 1482/4885KMT2A 1411/4885 |
| US-12540262-B2 | Two component (2K) curable adhesive composition | ILK, MAT2A, MMAB | MEN1 2290/4885HSP90AA1 265/4885KMT2A 512/4885 |
| US-20260088410-A1 | ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS | EPCAM, CDH1, ITGA4 | MEN1 2502/4885HSP90AA1 3206/4885KMT2A 2215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.